Directory · IL
Biotechnology in Israel
A register of firms and the professionals working at them in the Biotechnology sector based in Israel. Browse the public index, then filter or export on Kipplo.
Companies
89 on file
Dr. Golik
Dr. Golik is a leading supplier of advance scientific instrumentation, technical service and application support that apply advanced technologies for accurate analysis and characterization of: chemical ions, particles, GPC, zeta potential, powdered and porous materials properties etc. We supply solutions in the fields of evaporation, separation, titration, spectroscopy AA, ICP,NIR, rheology, electrochemistry, spray dry, encapsulation, SEM microscopy, particle size, particle shape and more. Dr. Golik's team assigns specialists focused on servicing customers, needs and systems in a variety of different fields and applications. Dr. Golik operates from Tel-Aviv.
11 to 50 staff
Nrgene Ltd
NRGene applies innovative cloud-based-#genomics and data-driven insights to optimize natural resources for #foodsecurity and #sustainable #agriculture Visit our website for more information
51 to 200 staff
Curesponse
Personalized Medicine for Accurate Cancer Treatment
11 to 50 staff
Ydlabs
YDLabs provides Agri-Foodtech companies with fermentation process development and process optimization services, from lab scale to Our facilities include state-of-the-art fermenters (1-10L), 80L, 300L & as well as comprehensive purification and isolation downstream equipment. Our technical team is highly experienced, to provide fast, results-driven service so our clients are able to move forward to the next scale-up with a scalable and sustainable process. We work with companies worldwide and provide them with online data, constant updates, and consultations about their projects. Our fermentation experience and knowledge, our state-of-the-art equipment, and our excellent service have helped multiple companies accelerate their process development significantly, saving them a lot of money and time towards a successful and scalable process.
11 to 50 staff
Granalix Bio Technologies Ltd
As a startup biotechnology company, Granalix is dedicated to advancing the field of healthcare through innovation and cutting-edge research. Founded by two renowned professors, Prof. Ruth Gabizon from the Neurology Department of the Hadassah Medical Center and Prof. Shlomo Magdassi from the Casali Institute of Chemistry of The Hebrew University, Granalix represents the culmination of their combined experience and knowledge. Specializing in the development of biotechnology products, Granalix is committed to producing innovative solutions that address the most pressing healthcare challenges facing society today. The company's flagship product, Granagard, is the result of extensive research and development, and is poised to revolutionize the way we approach healthcare. As a startup, Granalix operates under the umbrella of Hadasit and Yissum, the technology transfer companies of Hadassah Medical Center and the Hebrew University of Jerusalem. This unique partnership allows the company to leverage the resources and expertise of two of the world's leading healthcare institutions, enabling it to accelerate its research and development efforts and bring new products to market more quickly. At Granalix, we are driven by a deep passion for improving healthcare outcomes and enhancing quality of life for people around the world. We are committed to pushing the boundaries of biotechnology and developing innovative solutions that have the potential to transform the field of healthcare as we know it.
11 to 50 staff
Diptera.Ai
Developing technology to fight pests with pests. Diptera's ultimate mission is to fight the spread of mosquito-borne diseases, including Zika, West Nile, Chikungunya, dengue, and malaria, by targeting the very insects that spread them. Diptera is focused on advancing methods for sex-sorting pre-adult insects, aiming to enhance techniques in controlling mosquito populations. This innovation could be pivotal in biological control strategies where only one sex, typically males, is released to suppress mosquito breeding.
11 to 50 staff
Futurx
FutuRx is a biotech incubator founded by three leading global healthcare players – Takeda (Takeda Ventures Inc.), Johnson & Johnson (JJDC), and OrbiMed Israel Partners. By combining the expertise of its management and the capabilities of its founders, FutuRx provides a unique model for the transformation of breakthrough discoveries into novel medicines. FutuRx leverages its access to the Israeli biotech industry, and to leading research institutes in Israel and worldwide, to identify and develop highly innovative technologies. Experts at Takeda, J&J, and OrbiMed are deeply involved in the project selection process and during the incubator period of each company. The result is a clear impact on the efficient translation of innovative research to clinically meaningful products.
11 to 50 staff
Matricelf
Why Matricelf? Every year, thousands of lives are forever changed by spinal cord injury (SCI)—a devastating event that strips individuals of their movement, independence, and dignity. At Matricelf, we believe this isn’t the end of the story. It’s the beginning of a new one—written by science, driven by compassion. What We Do Matricelf is a pioneering biotech company in the field of regenerative medicine, developing a curative, one-time treatment to help individuals with spinal cord injuries regain control over their lives. Our approach uses engineered human tissue, derived from a patient’s own cells, to repair damaged spinal cords—restoring not just movement, but hope. Why It Matters We’re not just growing tissue. We’re rebuilding futures. Our breakthrough holds the promise of returning the ability to walk, to work, to hug loved ones—fundamental human experiences most of us take for granted. Our Promise Still in the pre-clinical stage, Matricelf is backed by leading scientists, top-tier innovation, and a mission bigger than ourselves. We stand at the frontier of medicine, not only advancing science but rewriting what’s possible for millions. Prestige Meets Purpose Founded by world-renowned experts and recognized on global stages, Matricelf blends credibility with heart. We offer more than a treatment—we offer hope with proof, dignity with data, and a future rooted in science. Join Us Because when we restore a spinal cord, we restore a life.
11 to 50 staff
Asterix Foods
Industry leading companies like Impossible, Perfect Day (RebelBio), and EVERY (IndieBio) have shown the powerful commercial appeal of animal-free proteins. Behind this first wave comes a second wave: glycoproteins. Glycoproteins require precise glycosylations to accurately fold, recognize, and bind – driving functional performance needed in the food industry. To unlock this second wave of animal-free proteins, Asterix Foods is using plant cells, because plant cells can easily achieve glycosylations that microbial fermentation is challenged by.
1 to 10 staff
Biogencell Ltd
BioGenCell was founded with the vision of developing safe, effective, and long-lasting effective treatment for incurable, blood vessel diseases that will be both accessible and patient friendly. Our disruptive TRACT technology platform provides a comprehensive approach for rapid manufacturing and commercialization of cell-therapies.
11 to 50 staff
Breath Of Health
Breath of Health (BOH) is a cutting edge, breath-based technology offering quick, noninvasive, early detection of disease, including Covid-19. The low-cost diagnostic, which identifies over 500 particles through its proprietary AI software, has been extensively tested at renowned hospitals with proven success. Through molecular analysis, BOH is able to detect early responses in the immune system, even in the asymptomatic stages. With pre-approval from regulators including the FDA, its international patented algorithm can accurately diagnose Covid-19. The company has now begun clinical studies in five global locations. With distribution agreements with over 20 countries (awaiting FDA approval), BOH is already capable of conducting tests per day with results given within one minute or less. One of the biggest benefits of this disease-recognition system is the relative low cost of testing, offering more people a chance at early detection and improved health outcomes. Breath of Health is revolutionary in providing accessible, preventative medical testing for a range of medical conditions.
1 to 10 staff
Qrgenetics
QRGenetics is transforming the treatment of genetic diseases through GenAI-driven precision medicine. Our platform identifies and validates novel therapeutic targets by uncovering disease mechanisms in rare genetic conditions, rapidly matching them with clinically-proven, FDA-approved drugs and monitoring their validation in human trials. Leveraging these groundbreaking insights, QRGenetics then applies advanced AI analytics across extensive datasets to pinpoint similar targets in more common diseases. By partnering closely with pharmaceutical companies, we accelerate drug discovery, significantly reduce clinical risks, and bring effective treatments to broader patient populations faster. Join us on our journey to redefine precision medicine. Learn more: qrgenetics.com
1 to 10 staff
Flask Data
Flask Data is a Digital CRO. We make clinical data management simple. Flask Data is a Digital Clinical Research Organization. We specialize in executing medtech and digital therapeutics studies. Since 2019, over 10M signals, 70+ studies, 5 FDA approvals. 95% protocol compliance in neurology indications. The Flask Data Digital CRO platform helps you achieve high protocol compliance and patient retention in a flat-rate, unlimited usage monthly subscription. Challenge us. We will stand by you in good and bad times with fanatic service, straight-talk and the highest professional and ethical standards. Over 10M signals, 70+ studies, 5 FDA approvals. 95% protocol compliance in neurology indications. The Flask Data EDC Collect, Detect and Act platform helps you achieve high protocol compliance and patient retention with low headcount and high ROI. All this, in a flat-rate, unlimited usage monthly subscription. Challenge us. We will stand by you in good and bad times with fanatic service, straight-talk and the highest professional and ethical standards Our decentralized, innovative, and adaptive solutions minimize risks to clinical data, patient safety, and protocol compliance. Flas Data solutions are automated, scalable, and adaptive to the needs of each research. Flask data enables you to assure patient compliance no matter where your patients are or what device they have. Security and privacy are baked in by design by world-class Israeli cyber specialists. The Flaskdata.io platform complies with HIPAA, CCPA, GDPR, 21 CFR Part 11, and Israeli Privacy Regulations. We work with big, publicly-traded companies and three-person startups. Thousands of patients around the world and hundreds of research sites use Flask Data solutions, developed specifically for innovative companies like yours.
11 to 50 staff
Nectin Therapeutics
Nectin Therapeutics is a biotech company focused on unlocking the power of the immune system. We are developing a collection of next-generation immunotherapy agents. Despite the unprecedented efficacy of existing immunotherapy agents, many patients either fail to respond, or following encouraging initial response, develop resistance over time. At Nectin, we have discovered novel resistance mechanisms and developed novel agents targeting these mechanisms for improved therapy. At Nectin, we are dedicated to the development of novel therapeutic options for cancer patients. We are developing a diverse pipeline of targeted antibodies based on the nectin pathways. These antibodies overcome inhibitory pathways deployed by the tumors and allow immune cells to effectively destroy cancer cells. Additionally, based on the unique expression patterns of several nectin proteins, we develop CAR-T and -NK drivers that directly target tumor cells in various indications, including hard-to-treat cancers.
1 to 10 staff
Alma Therapeutics - Oral Biologics Revolution
Alma Therapeutics is developing a novel drug delivery platform for the oral delivery of complex molecules and biologics such as: Peptides, Proteins and Antibodies
1 to 10 staff
Nanorobotics
Nanorobotics has developed a proprietary technology to target and kill cancer cells promptly via the use of Molecular NanoMachines. These tiny machines (size 1 nm) can kill the cell mechanically by drilling and tunneling through the membrane until disrupting its nucleus. We are bringing a new modality to oncology - Mechanotherapy. Our recent animal studies have shown dramatic reduction of melanoma growth that is highly resistant to immunotherapy. And the great news - our Mechanotherapy treatment is decoupled from any cancer pathogenesis, mutational rate, or tumor microenvironment. Our programmable, light-activated, nanorobots open a revolutionary new area in nanomedicine. https://nanorobotics.tech
1 to 10 staff
Newstem Ltd
NewStem is a biopharmaceutical company focused on Human Pluripotent Stem Cells (HPSCs) in general and Human Haploid Pluripotent Stem Cells (HHPSCs) in particular. These cells have the potential to change the face of medical research as they hold a pivotal role in regenerative medicine, disease therapy and cancer research. NewStem possesses pioneering intellectual property, reagents and experience related to the isolation and differentiation of HPSCs, their genetic manipulation, immunogenicity, tumorigenicity and their unique capacity in disease modeling. With this innovative research, and specialized drug and gene screening capabilities. NewStem is currently the only company worldwide to develop products based on this paradigm changing proprietary tech-nology, licensed from Yissum, Hebrew University’s technology transfer company, based on the findings and in-ventions of Prof. Nissim Benvenisty, of the Azrieli Center for Stem Cells and Genetic Research, The Hebrew University of Jerusalem.
1 to 10 staff
Sensiu By Kaizen Biotech Ltd
Nice to Meet You, We Are Kaizen! Our mission is to impact the next generation’s health by empowering nursing families. We are pioneering a new category of insight-based support for nursing families, creating two innovative breastfeeding tools designed to empower families and support lactation professionals with clear, actionable insights that enhance care. Together, we can create a future where every nursing family has the support they need to thrive.
11 to 50 staff
Immunovative Therapies Ltd
Immunovative Therapies, Ltd.(Jerusalem) and our subsidiaries, Immunovative Clinical Research, Inc.(USA) and Immunovative (Thailand) Co, Ltd.(Bangkok) is the licensor and exclusive consultant to Mirror Biologics, Inc.(Tampa) and Mirror Biologics, Ltd.(Jerusalem). As exclusive consultants, we assist and provide support to Mirror to advance our immunotherapy drug candidate,AlloStim, to commercialization. We provide drug depo management, blood donor center support, clinical site management services. In addition, we are actively collaborating with Mirror to design and build automated commercial-scale cell manufacturing pods and plug-and-play disposable sets and assisting to operate a clinical research center in Tampa and Bangkok.
1 to 10 staff
Insectprojects
InsectProjects main goal is to support companies that upscale or enter the BSF industry, by providing first-hand experience and unique skills, throughout the BSF project realization process.
1 to 10 staff
Selene Therapeutics
Selene Therapeutics is pioneering a new therapeutic strategy for treating refractory epilepsy – regulation of the neuronal activity set point by reduction of the neuronal mean firing rate (MFR).
1 to 10 staff
Circuit-Bio Ltd
Circuit-Bio is a synthetic biology company developing an innovative unique platform of logical gene circuits for cancer immunotherapy.
1 to 10 staff
Lutris Pharma
Lutris Pharma is a clinical stage biopharmaceutical company focused on improving anti-cancer therapy effectiveness and quality of life for patients who are being treated with EGFR (Epidermal Growth Factor Receptor) inhibitors or with radiation, where dermal toxicity often leads to a reduction of anti-cancer therapy compliance. The company aims to provide novel topical therapies in order to mitigate these side effects. Lutris Pharma’s lead asset, LUT014, a topical B-Raf Inhibitor, is a proprietary, first-in-class, small molecule currently in a phase 2 clinical trial in metastatic colorectal cancer patients with EGFR inhibitor induced acneiform lesions and a phase 1/2 study for the treatment of radiation-induced dermatitis.
11 to 50 staff
21 West Partners
21 West Partners develops and implements momentum strategies to accelerate ad sustain the profitable growth of brands and companies. 21 West Partners acts as advisors to senior management on issues of leadership, brand strategy & communication and business development. 21 West Partners also gets involved directly as principles or partners in new ventures. Our experience is across industries but we have specific expertise in Bio-tech, Med-tech, High-Tech, Hospitality & Real Estate, Health & Wellness and Luxury Goods.
1 to 10 staff
